$STX

MOSLEY WILLIAM D sold $1.6M of STX

MOSLEY WILLIAM D (CEO) sold 1,691 shares of Seagate Technology Holdings plc (STX) at $919.62 ($1.56M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MOSLEY WILLIAM D
Published Jun 2, 2026, 9:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
medium confidence
Mentioned
$STX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

This disclosure can slightly influence short-term sentiment, but it is not a new operational or financial catalyst for STX.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing generally limits fundamental read-through.

03

What to watch

The disclosed share count/value may be part of a broader, pre-set selling schedule; without the full plan details, interpreting intent is unreliable.

Relevance 6/10Novelty 6/10Timing: Filed after-hours/late day (2026-06-02 17:16 ET filing time) for next session positioning

Background

SEC Form 4 reports insider transactions; 10b5-1 plans are pre-arranged trading schedules intended to reduce timing/insider-information concerns.

Company-level read

Ticker impact

$STXNeutralMedium confidence
Context

Seagate CEO William D. Mosley sold $1.56M of STX shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely modest and sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a routine insider sale with stated 10b5-1 plan usage, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity rather than a sector catalyst.

None expected beyond US large-cap sentiment.

None expected.

Counterpoint

Because the sale is 10b5-1 pre-arranged, it may reflect scheduled liquidity needs rather than bearish expectations; any dip could be overdone.

Key entities

  • Seagate Technology Holdings plc

    Subject of the Form 4 insider transaction; CEO William D. Mosley sold STX shares.

  • William D. Mosley

    CEO/officer/director who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.